Drug-Resistant TB Continues To Pose Threat To Global Health; TB Community Must Adopt Human Rights-Based Approach To Ending Disease

Forbes: Drug-Resistant TB: A Clear And Present Danger
Madhukar Pai, Canada research chair in epidemiology & global health and director of global health programs and the McGill TB Centre at McGill University

“…Drug-resistant TB is [a] classic example of the dangers posed by antimicrobial resistance (AMR) … [On Tuesday,] The Economist Intelligence Unit (EIU) published a report entitled ‘It’s Time to End Drug-Resistant Tuberculosis.’ … The report makes … key observations. [Drug-resistant TB (DR-TB)] poses a significant threat to global health security, yet gets little funding. … DR-TB imposes a huge economic burden, on families and countries. … The case for investing in DR-TB is compelling and strong. … There is growing global commitment to fight DR-TB — but it is time for action. … [C]ountry leaders must be held accountable for meeting their SDG targets, and here, public engagement and advocacy is critical. The HIV field has greatly benefited from patient advocacy and a human-rights approach that is centered on helping people, not just disease control. It is time for the TB community to harness the power of patient advocacy and adopt a human rights-based approach for ending TB” (5/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.